home / stock / vrpx / vrpx news


VRPX News and Press, Virpax Pharmaceuticals Inc. From 06/02/25

Stock Information

Company Name: Virpax Pharmaceuticals Inc.
Stock Symbol: VRPX
Market: NASDAQ
Website: virpaxpharma.com

Menu

VRPX VRPX Quote VRPX Short VRPX News VRPX Articles VRPX Message Board
Get VRPX Alerts

News, Short Squeeze, Breakout and More Instantly...

VRPX - Expected US Company Earnings on Monday, June 2nd, 2025

Hypha Labs Inc Com (New) (FUNI) is expected to report for Q2 2025 XTL Biopharmaceuticals Ltd. (XTLB) is expected to report for quarter end 2025-03-31 Onconetix Inc. (ONCO) is expected to report for quarter end 2025-03-31 Baosheng Media Group Holdings Limited (BAOS) is expected to repo...

VRPX - Expected US Company Earnings on Monday, May 26th, 2025

Lufax Holding Ltd American Depositary Shares each representing two (2) (LU) is expected to report for Q1 2025 RiceBran Technologies (RIBT) is expected to report for quarter end 2025-03-31 Novo Integrated Sciences Inc. (NVOS) is expected to report for quarter end 2025-02-28 Voestalpine...

VRPX - Expected US Company Earnings on Monday, May 19th, 2025

Global Ship Lease Inc New Class A (GSL) is expected to report $2.27 for Q1 2025 Biolase Inc. (BIOLQ) is expected to report for quarter end 2025-03-31 ViewBix Inc (VBIXD) is expected to report for Q1 2025 8x8 Inc (EGHT) is expected to report $0.01 for Q4 2025 Gaucho Group Hol (VINO...

VRPX - Expected US Company Earnings on Monday, May 12th, 2025

Redwire Corporation (RDW) is expected to report $-0.2 for Q1 2025 Organigram Global Inc. (OGI) is expected to report $-0.03 for Q2 2025 Inter & Co. Inc. (INTR) is expected to report $0.12 for Q1 2025 Pervasip Corp (PVSP) is expected to report for quarter end 2025-02-28 Maui La...

VRPX - VRPX announced stock split 1-25

2025-03-21 09:01:56 ET Virpax Pharmaceuticals, Inc. (VRPX) announced stock split at a ratio of 1-for-25 on 2025-03-21 ... Full story available on KlickAnalytics.com

VRPX - Virpax Pharmaceuticals to conduct reverse stock split

2025-03-19 08:12:14 ET More on Virpax Pharmaceuticals Seeking Alpha’s Quant Rating on Virpax Pharmaceuticals Historical earnings data for Virpax Pharmaceuticals Read the full article on Seeking Alpha For further details see: Virpax Pharmaceuticals ...

VRPX - Virpax Pharmaceuticals Announces Reverse Stock Split

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”) a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today ann...

VRPX - Virpax Receives Positive Probudur(TM) Results for Dose Range Study Moves Towards Next Steps in IND

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”) , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today...

VRPX - Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”) , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, is lo...

VRPX - Virpax's NES100 to be Presented at The Society of Toxicology by NCATS

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”) , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, is pl...

Previous 10 Next 10